Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Nanomedicine. 2019 Jun 4;20:102025. doi: 10.1016/j.nano.2019.102025

Figure 2: Cytotoxicity Profiles of dMWCNTs vs PEG-dMWCNTs.

Figure 2:

Cytotoxicity assay comparing multiple cell types over a 24 and 48-hour treatment period with various doses of dMWCNTs and PEG-dMWCNTs (A) OPM2, (B) hMSCs, (C) 3T3L1 cells. Statistics were done using 2-way ANOVA with Sidak’s multiple comparisons test at 24 and 48 hours for each cell line, n=4-6.